SUBSCRIBERS
Large-scale study of NSAIDS finds no link to heart attack
Celebrex is less likely than naproxen and ibuprofen to cause kidney and gastrointestinal problems
Add BT as a preferred sourcePublished Mon, Nov 14, 2016 · 09:50 PM
Washington
IN 2004, when drugmaker Merck voluntarily pulled the pain-reliever Vioxx off the market amid evidence that it increased the risk of heart attacks, concern naturally turned to its nearly identical rival, Celebrex.
The medication works the same way, by inhibiting production of an enzyme that causes pain and inflammation - as do naproxen, ibuprofen and others in the class of widely used analgesics known as non-steroidal anti-inflammatory drugs (NSAIDS).
Share with us your feedback on BT's products and services
